Month: May 2026

Novel SA-53 MDM2 Inhibitor Therapy Has Potential to be a Breakthrough in Genetically Targeted Cancer Treatment (CLEVELAND, OH) – Steady progress for Lamassu Biotech’s potentially transformative cancer treatment. The private, pioneering...